$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Option Exercise | A | 10.71 | 36,111 | 386,749 | 36,111 | |
Jun 14 2021 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Grant | A | 0.00 | 10,115 | 0 | 31,115 | 21 K to 31.1 K (+48.17 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.38 | 1,443 | 6,320 | 134,935 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 20,557 | 132,593 | 0 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.01 | 29,500 | 295,192 | 877,230 | 906.7 K to 877.2 K (-3.25 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 4.38 | 1,443 | 6,320 | 906,730 | 905.3 K to 906.7 K (+0.16 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 20,557 | 132,593 | 905,287 | 884.7 K to 905.3 K (+2.32 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.38 | 3,891 | 17,043 | 66,088 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 6,623 | 42,718 | 0 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 3.53 | 12,345 | 43,578 | 65,655 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.52 | 10,653 | 26,846 | 0 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.94 | 15,223 | 44,756 | 74,777 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.45 | 24,375 | 59,719 | 65,625 | |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 10,514 | 105,207 | 457,268 | 467.8 K to 457.3 K (-2.25 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 4.38 | 3,891 | 17,043 | 467,782 | 463.9 K to 467.8 K (+0.84 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 6,623 | 42,718 | 463,891 | 457.3 K to 463.9 K (+1.45 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 10.08 | 17,350 | 174,888 | 457,268 | 474.6 K to 457.3 K (-3.66 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 3.53 | 12,345 | 43,578 | 474,618 | 462.3 K to 474.6 K (+2.67 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 2.52 | 10,653 | 26,846 | 462,273 | 451.6 K to 462.3 K (+2.36 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 2.94 | 15,223 | 44,756 | 451,620 | 436.4 K to 451.6 K (+3.49 %) |
Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 2.45 | 24,375 | 59,719 | 436,397 | 412 K to 436.4 K (+5.92 %) |
Jun 02 2021 | FOLD | AMICUS THERAPEUTIC ... | WHITMAN BURKE W | Director | Buy | P | 9.24 | 1,500 | 13,861 | 47,467 | 46 K to 47.5 K (+3.26 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 7.51 | 10,000 | 75,100 | 0 | |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 10.27 | 10,000 | 102,704 | 27,919 | 37.9 K to 27.9 K (-26.37 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 7.51 | 10,000 | 75,100 | 37,919 | 27.9 K to 37.9 K (+35.82 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | WHITMAN BURKE W | Director | Buy | P | 10.21 | 1,500 | 15,315 | 45,967 | 44.5 K to 46 K (+3.37 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.28 | 7,500 | 77,089 | 884,730 | 892.2 K to 884.7 K (-0.84 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 10,514 | 67,815 | 6,623 | |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.27 | 10,514 | 107,970 | 412,022 | 422.5 K to 412 K (-2.49 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 10,514 | 67,815 | 422,536 | 412 K to 422.5 K (+2.55 %) |
Apr 26 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.01 | 7,683 | 76,898 | 892,230 | 899.9 K to 892.2 K (-0.85 %) |
Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 10.33 | 660 | 6,818 | 88,215 | 88.9 K to 88.2 K (-0.74 %) |
Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 24,201 | 0 | 88,875 | 64.7 K to 88.9 K (+37.42 %) |
Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 20,557 | |
Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.09 | 22,000 | 222,086 | 899,913 | 921.9 K to 899.9 K (-2.39 %) |
Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 921,913 | 899.9 K to 921.9 K (+2.44 %) |
Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Grant | A | 0.00 | 16,883 | 0 | 174,389 | 157.5 K to 174.4 K (+10.72 %) |
Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 20,501 | 0 | 448,617 | 428.1 K to 448.6 K (+4.79 %) |
Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 78,389 | 0 | 899,913 | 821.5 K to 899.9 K (+9.54 %) |
Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 33,165 | 0 | 412,022 | 378.9 K to 412 K (+8.75 %) |
Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 19,295 | 0 | 290,629 | 271.3 K to 290.6 K (+7.11 %) |
Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 20,501 | 0 | 241,206 | 220.7 K to 241.2 K (+9.29 %) |
Mar 30 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | A | 10.03 | 13,768 | 138,093 | 13,768 | |
Mar 30 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 9.59 | 435 | 4,172 | 64,674 | 65.1 K to 64.7 K (-0.67 %) |
Mar 30 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 30,181 | 0 | 65,109 | 34.9 K to 65.1 K (+86.41 %) |
Mar 30 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 8,673 | 0 | 34,928 | 26.3 K to 34.9 K (+33.03 %) |
Mar 24 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.29 | 7,682 | 79,061 | 829,024 | 836.7 K to 829 K (-0.92 %) |
Mar 17 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 42,557 | |
Mar 17 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.77 | 22,000 | 236,988 | 836,706 | 858.7 K to 836.7 K (-2.56 %) |
Mar 17 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 858,706 | 836.7 K to 858.7 K (+2.63 %) |
Mar 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 16,628 | 48,886 | 0 | |
Mar 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 10.48 | 4,664 | 48,879 | 271,334 | 276 K to 271.3 K (-1.69 %) |
Mar 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 16,628 | 48,886 | 275,998 | 259.4 K to 276 K (+6.41 %) |
Feb 24 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.98 | 7,682 | 92,027 | 844,206 | 851.9 K to 844.2 K (-0.90 %) |
Feb 18 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 64,557 | |
Feb 18 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.26 | 22,000 | 269,700 | 851,888 | 873.9 K to 851.9 K (-2.52 %) |
Feb 18 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 873,888 | 851.9 K to 873.9 K (+2.58 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 21.84 | 8,794 | 192,017 | 220,705 | 229.5 K to 220.7 K (-3.83 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 20,731 | 0 | 229,499 | 208.8 K to 229.5 K (+9.93 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 21.84 | 4,770 | 104,153 | 259,370 | 264.1 K to 259.4 K (-1.81 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 9,502 | 0 | 264,140 | 254.6 K to 264.1 K (+3.73 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 21.84 | 9,960 | 217,477 | 428,116 | 438.1 K to 428.1 K (-2.27 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 22,458 | 0 | 438,076 | 415.6 K to 438.1 K (+5.40 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 86,557 | |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 21.51 | 50,000 | 1,075,325 | 859,388 | 909.4 K to 859.4 K (-5.50 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 22.24 | 22,000 | 489,368 | 909,388 | 931.4 K to 909.4 K (-2.36 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 931,388 | 909.4 K to 931.4 K (+2.42 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 21.84 | 31,608 | 690,161 | 909,388 | 941 K to 909.4 K (-3.36 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 80,327 | 0 | 940,996 | 860.7 K to 941 K (+9.33 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 21.84 | 14,463 | 315,800 | 378,857 | 393.3 K to 378.9 K (-3.68 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 29,367 | 0 | 393,320 | 364 K to 393.3 K (+8.07 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 21.78 | 185,585 | 4,042,041 | 185,585 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 115,240 | 0 | 860,669 | 745.4 K to 860.7 K (+15.46 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 22.17 | 7,500 | 166,305 | 745,429 | 752.9 K to 745.4 K (-1.00 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 19,994 | 461,661 | 752,929 | 772.9 K to 752.9 K (-2.59 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 22,968 | 530,331 | 772,923 | 795.9 K to 772.9 K (-2.89 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 11,335 | 261,725 | 795,891 | 807.2 K to 795.9 K (-1.40 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 16,287 | 376,067 | 807,226 | 823.5 K to 807.2 K (-1.98 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Option Exercise | A | 21.78 | 53,355 | 1,162,072 | 53,355 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Grant | A | 0.00 | 33,131 | 0 | 208,768 | 175.6 K to 208.8 K (+18.86 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 23.09 | 8,306 | 191,786 | 175,637 | 183.9 K to 175.6 K (-4.52 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 23.09 | 6,475 | 149,508 | 183,943 | 190.4 K to 183.9 K (-3.40 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | Chief Legal Officer | Payment of Exercise | F | 23.09 | 4,751 | 109,701 | 190,418 | 195.2 K to 190.4 K (-2.43 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | A | 21.78 | 16,963 | 369,454 | 16,963 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Grant | A | 0.00 | 10,533 | 0 | 26,255 | 15.7 K to 26.3 K (+67.00 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Payment of Exercise | F | 23.09 | 1,413 | 32,626 | 15,722 | 17.1 K to 15.7 K (-8.25 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 21.78 | 55,675 | 1,212,602 | 55,675 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 34,572 | 0 | 415,618 | 381 K to 415.6 K (+9.07 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 8,938 | 206,378 | 381,046 | 390 K to 381 K (-2.29 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 14,358 | 331,526 | 389,984 | 404.3 K to 390 K (-3.55 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 5,340 | 123,301 | 404,342 | 409.7 K to 404.3 K (-1.30 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Option Exercise | A | 21.78 | 44,076 | 959,975 | 44,076 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Grant | A | 0.00 | 27,369 | 0 | 157,506 | 130.1 K to 157.5 K (+21.03 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Payment of Exercise | F | 23.09 | 10,974 | 253,390 | 130,137 | 141.1 K to 130.1 K (-7.78 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 21.78 | 53,355 | 1,162,072 | 53,355 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 33,131 | 0 | 254,638 | 221.5 K to 254.6 K (+14.96 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 5,053 | 116,674 | 221,507 | 226.6 K to 221.5 K (-2.23 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 15,164 | 350,137 | 226,560 | 241.7 K to 226.6 K (-6.27 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 2,620 | 60,496 | 241,724 | 244.3 K to 241.7 K (-1.07 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 21.78 | 92,792 | 2,021,010 | 92,792 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 10,514 | 67,815 | 48,679 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 57,620 | 0 | 363,953 | 306.3 K to 364 K (+18.81 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 22.17 | 10,514 | 233,125 | 306,333 | 316.8 K to 306.3 K (-3.32 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 10,514 | 67,815 | 316,847 | 306.3 K to 316.8 K (+3.43 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 13,974 | 322,660 | 306,333 | 320.3 K to 306.3 K (-4.36 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 26,908 | 621,306 | 320,307 | 347.2 K to 320.3 K (-7.75 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 7,617 | 175,877 | 347,215 | 354.8 K to 347.2 K (-2.15 %) |
Dec 23 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 5,000 | 14,700 | 16,628 | |
Dec 23 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Sell | S | 24.09 | 5,000 | 120,474 | 244,344 | 249.3 K to 244.3 K (-2.01 %) |
Dec 23 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 5,000 | 14,700 | 249,344 | 244.3 K to 249.3 K (+2.05 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.45 | 6,892 | 16,885 | 0 | |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 3.53 | 4,379 | 15,458 | 0 | |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 4.38 | 7,550 | 33,069 | 0 | |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 11,500 | 33,810 | 21,628 | |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.86 | 4,156 | 99,162 | 244,344 | 248.5 K to 244.3 K (-1.67 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.45 | 6,892 | 16,885 | 248,500 | 241.6 K to 248.5 K (+2.85 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 3.53 | 4,379 | 15,458 | 241,608 | 237.2 K to 241.6 K (+1.85 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 4.38 | 7,550 | 33,069 | 237,229 | 229.7 K to 237.2 K (+3.29 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 11,500 | 33,810 | 229,679 | 218.2 K to 229.7 K (+5.27 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.38 | 10,021 | 43,892 | 69,979 | |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 10,807 | 69,705 | 59,193 | |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.86 | 4,760 | 113,574 | 354,832 | 359.6 K to 354.8 K (-1.32 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 4.38 | 10,021 | 43,892 | 359,592 | 349.6 K to 359.6 K (+2.87 %) |
Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 10,807 | 69,705 | 349,571 | 338.8 K to 349.6 K (+3.19 %) |
Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 108,557 | |
Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 23.91 | 22,000 | 526,101 | 823,513 | 845.5 K to 823.5 K (-2.60 %) |
Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 845,513 | 823.5 K to 845.5 K (+2.67 %) |
Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 23.88 | 111,125 | 2,653,276 | 409,682 | 520.8 K to 409.7 K (-21.34 %) |
Dec 02 2020 | FOLD | AMICUS THERAPEUTIC ... | Kelly Michael Aaron | Director | Option Exercise | A | 22.63 | 14,222 | 321,844 | 14,222 | |
Dec 02 2020 | FOLD | AMICUS THERAPEUTIC ... | Kelly Michael Aaron | Director | Grant | A | 0.00 | 8,837 | 0 | 8,837 | 0 to 8.8 K |
Nov 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | M | 10.04 | 594 | 5,964 | 5,148 | |
Nov 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Option Exercise | M | 14.88 | 5,337 | 79,415 | 2,940 | |
Nov 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Sell | S | 20.00 | 5,931 | 118,620 | 17,135 | 23.1 K to 17.1 K (-25.71 %) |
Nov 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Buy | M | 10.04 | 594 | 5,964 | 23,066 | 22.5 K to 23.1 K (+2.64 %) |
Nov 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Prout Samantha | Principal Accountin ... | Buy | M | 14.88 | 5,337 | 79,415 | 22,472 | 17.1 K to 22.5 K (+31.15 %) |
Oct 20 2020 | FOLD | AMICUS THERAPEUTIC ... | Clark David Michael | Chief People Office ... | Payment of Exercise | F | 15.12 | 5,510 | 83,284 | 141,111 | 146.6 K to 141.1 K (-3.76 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 9.03 | 75,000 | 677,250 | 0 | |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 12.28 | 75,000 | 921,000 | 0 | |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 8.61 | 43,700 | 376,257 | 0 | |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 15.03 | 193,700 | 2,911,272 | 520,807 | 714.5 K to 520.8 K (-27.11 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 9.03 | 75,000 | 677,250 | 714,507 | 639.5 K to 714.5 K (+11.73 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 12.28 | 75,000 | 921,000 | 639,507 | 564.5 K to 639.5 K (+13.29 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 8.61 | 43,700 | 376,257 | 564,507 | 520.8 K to 564.5 K (+8.39 %) |
Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | WHITMAN BURKE W | Director | Buy | P | 14.28 | 1,500 | 21,413 | 35,467 | 34 K to 35.5 K (+4.42 %) |
Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 20,000 | 119,200 | 23,975 | |
Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.02 | 29,900 | 419,105 | 840,913 | 870.8 K to 840.9 K (-3.43 %) |
Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.96 | 20,000 | 119,200 | 870,813 | 850.8 K to 870.8 K (+2.35 %) |
Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.45 | 11,000 | 26,950 | 6,892 | |
Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 5,000 | 14,700 | 33,128 | |
Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.45 | 11,000 | 26,950 | 218,179 | 207.2 K to 218.2 K (+5.31 %) |